$TRXA
T-REX Acquisition Corp.

2022 Q1 Form 10-Q Financial Statement

#000147793222000966 Filed on February 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2020 Q4
Revenue $26.31K $0.00 $0.00
YoY Change
Cost Of Revenue $39.65K $0.00
YoY Change
Gross Profit -$13.35K $0.00
YoY Change
Gross Profit Margin -50.75%
Selling, General & Admin $79.96K $840.8K $41.48K
YoY Change 82.14% 1927.03% 157.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $79.96K $840.8K $41.48K
YoY Change 82.14% 1927.06% 55.88%
Operating Profit -$93.31K -$840.8K -$41.48K
YoY Change 112.55% 1927.06%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$93.31K -$840.8K -$41.48K
YoY Change 112.55% 1927.06% 52.05%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$93.31K -$840.8K -$41.48K
YoY Change 112.55% 1927.06% 52.04%
Net Earnings / Revenue -354.73%
Basic Earnings Per Share
Diluted Earnings Per Share -$5.771K -$52.00K -$3.206K
COMMON SHARES
Basic Shares Outstanding 16.17M shares 16.17M shares
Diluted Shares Outstanding 16.17M shares 12.94M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.33K $1.360K $0.00
YoY Change
Cash & Equivalents $20.03K $1.360K $0.00
Short-Term Investments $26.31K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $46.33K $1.360K $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $437.5K $356.4K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.57K
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $448.1K $356.4K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $46.33K $1.360K $0.00
Total Long-Term Assets $448.1K $356.4K $0.00
Total Assets $494.4K $357.8K $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.97K $22.97K $0.00
YoY Change 22870.0% -100.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.97K $22.97K $1.070K
YoY Change 52871.0% 2046.82% -99.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $52.97K $22.97K $1.070K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $52.97K $22.97K $1.070K
YoY Change 52871.0% 2046.82% -99.76%
SHAREHOLDERS EQUITY
Retained Earnings -$3.874M -$3.780M
YoY Change
Common Stock $16.17K $16.17K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $441.5K $334.8K -$1.072K
YoY Change
Total Liabilities & Shareholders Equity $494.4K $357.8K $0.00
YoY Change

Cashflow Statement

Concept 2022 Q1 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income -$93.31K -$840.8K -$41.48K
YoY Change 112.55% 1927.06% 52.04%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$100.2K -$3.120K $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$81.14K -$356.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$81.14K -$356.4K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.0K 360.9K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -100.2K -3.120K 0.000
Cash From Investing Activities -81.14K -356.4K
Cash From Financing Activities 200.0K 360.9K 0.000
Net Change In Cash 18.68K 1.360K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$100.2K -$3.120K $0.00
Capital Expenditures -$81.14K -$356.4K
Free Cash Flow -$19.04K $353.3K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16169106 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1360 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1360 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
0 USD
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
356400 USD
CY2021Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
0 USD
CY2021Q4 us-gaap Assets
Assets
357760 USD
CY2021Q2 us-gaap Assets
Assets
0 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
22971 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1124 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
45000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22971 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
46124 USD
CY2021Q4 us-gaap Liabilities
Liabilities
22971 USD
CY2021Q2 us-gaap Liabilities
Liabilities
46124 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14669106 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
16169 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
14669 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3620116 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2805766 USD
CY2021Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
478925 USD
CY2021Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3780421 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2866559 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334789 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-46124 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
357760 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q4 us-gaap Revenues
Revenues
0 USD
CY2020Q4 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2021Q4 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
4433 USD
CY2020Q4 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
2479 USD
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
8566 USD
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
6018 USD
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
20406 USD
CY2020Q4 us-gaap Professional Fees
ProfessionalFees
24000 USD
us-gaap Professional Fees
ProfessionalFees
74330 USD
us-gaap Professional Fees
ProfessionalFees
42000 USD
CY2021Q4 us-gaap Management Fee Expense
ManagementFeeExpense
815850 USD
CY2020Q4 us-gaap Management Fee Expense
ManagementFeeExpense
15000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
830850 USD
us-gaap Management Fee Expense
ManagementFeeExpense
330000 USD
CY2021Q4 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
116 USD
CY2020Q4 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
0 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
116 USD
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
0 USD
CY2021Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
840805 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
41479 USD
us-gaap Operating Expenses
OperatingExpenses
913862 USD
us-gaap Operating Expenses
OperatingExpenses
378018 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-840805 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-41479 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-913862 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-378018 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
118049 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
80173 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21848 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2155 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3115 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16169106 shares
CY2021Q4 us-gaap Interest Expense
InterestExpense
0 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-840805 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-41479 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-913862 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-378018 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-840805 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-41479 USD
us-gaap Net Income Loss
NetIncomeLoss
-913862 USD
us-gaap Net Income Loss
NetIncomeLoss
-378018 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12940193 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15851171 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7844907 shares
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-389268 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-26616 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-415884 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-27281 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-443165 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-18004 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-461169 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-15674 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-476843 USD
CY2020Q3 trxa Shares Issued From Private Sale Amount
SharesIssuedFromPrivateSaleAmount
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
300000 USD
CY2020Q3 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
473616 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-336539 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-39766 USD
CY2020Q4 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
80173 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-41479 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1072 USD
CY2021Q1 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
44873 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-43901 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-100 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-46024 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-46124 USD
CY2021Q3 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
45000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-73057 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-74181 USD
CY2021Q4 trxa Shares To Be Issued For Subscriptions Received
SharesToBeIssuedForSubscriptionsReceived
360875 USD
CY2021Q4 trxa Share Based Expense For Warrants Issued
ShareBasedExpenseForWarrantsIssued
770850 USD
CY2021Q4 us-gaap Stock Issued1
StockIssued1
118050 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-840805 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334789 USD
us-gaap Net Income Loss
NetIncomeLoss
-913862 USD
us-gaap Net Income Loss
NetIncomeLoss
-378018 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
770850 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
356400 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
0 USD
us-gaap Payments To Acquire Land
PaymentsToAcquireLand
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-356400 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Proceeds From Loans
ProceedsFromLoans
360875 USD
us-gaap Proceeds From Loans
ProceedsFromLoans
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
360875 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1360 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1360 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
330000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
553789 USD
us-gaap Stock Issued1
StockIssued1
163050 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 USD
us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
1 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p>
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
793888 USD
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
trxa Deferred Tax Asset For Future Periods
DeferredTaxAssetForFuturePeriods
P20Y
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
793888 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
793888 USD
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
503709 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1168667 shares
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3780421 USD
CY2021Q4 trxa Working Capital Deficit
WorkingCapitalDeficit
-21611 USD
CY2021Q4 us-gaap Due To Officers Or Stockholders Current And Noncurrent
DueToOfficersOrStockholdersCurrentAndNoncurrent
43050 USD
CY2020Q1 trxa Shares Issued For Serivces Rendered Shares
SharesIssuedForSerivcesRenderedShares
300000 shares
CY2020Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
8900000 shares
CY2020Q2 trxa Common Stock Shares Issued Upon Debt Conversion Amount
CommonStockSharesIssuedUponDebtConversionAmount
473616 USD
CY2020Q3 trxa Prepayment For Future Expense
PrepaymentForFutureExpense
200198 USD
CY2021Q1 trxa Shares Issued For Serivces Rendered Shares
SharesIssuedForSerivcesRenderedShares
980000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
250000 shares
CY2021Q4 trxa Operating Loss Carryforward
OperatingLossCarryforward
-3780421 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
793888 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
503709 USD
trxa Management Fees
ManagementFees
60000 USD
CY2021Q4 trxa Due To Related Parties
DueToRelatedParties
118050 USD
CY2014Q2 trxa Exercise Price
ExercisePrice
0.80
CY2014Q2 trxa Description Of Warrants Exercise
DescriptionOfWarrantsExercise
Each Unit shall consist of (a) one (1) share of common stock and (b) a combination of series A warrants (which may be exercised within three (3) years) and series B warrants exercised within five (5) years of the consummation

Files In Submission

Name View Source Status
0001477932-22-000966-index-headers.html Edgar Link pending
0001477932-22-000966-index.html Edgar Link pending
0001477932-22-000966.txt Edgar Link pending
0001477932-22-000966-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trxa-20211231.xsd Edgar Link pending
trxa-20211231_cal.xml Edgar Link unprocessable
trxa-20211231_def.xml Edgar Link unprocessable
trxa-20211231_lab.xml Edgar Link unprocessable
trxa-20211231_pre.xml Edgar Link unprocessable
trxa_10q.htm Edgar Link pending
trxa_10q_htm.xml Edgar Link completed
trxa_ex311.htm Edgar Link pending
trxa_ex321.htm Edgar Link pending